RAD 2.22% 4.6¢ radiopharm theranostics limited

RAD media and Publications

  1. 247 Posts.
    lightbulb Created with Sketch. 195
    I thought I would create a media thread for RAD as I didn't see another one. Hopefully plenty of airplay to come

    https://thewest.com.au/business/public-companies/radiopharm-prepares-to-take-cancer-treatment-to-fda--c-8584737
    https://hotcopper.com.au/data/attachments/4762/4762425-371a2861692d3400ef1cf8158da6dd12.jpg
    https://hotcopper.com.au/data/attachments/4762/4762434-8389cf1912ef2d8f89654d07dda3a15c.jpg

    Although I believe there is a typo - It should state that the best case scenario would be if radiopharm were permitted to go strait to a phase III trial - Not phase II as stated in the article - effectively only one clinical trail away from commercialisation. As covered off by Ricardo on the webinar.

    Some other notes from Webinar I took down.

    - Clinical trials in imaging take less than other indications usually 6-9 months.
    - Mechanism of action is already proven from this trial.
    - Very good chance of being first to market, most advanced in the brain met indication.
    - The secondary stage of the drug will be a theranostic to arm the diagnostic with an isotope payload to treat the cancer using that binding method to deliver this payload.

    GLTA


 
watchlist Created with Sketch. Add RAD (ASX) to my watchlist
(20min delay)
Last
4.6¢
Change
0.001(2.22%)
Mkt cap ! $20.78M
Open High Low Value Volume
4.5¢ 5.0¢ 4.5¢ $31.57K 671.1K

Buyers (Bids)

No. Vol. Price($)
1 221118 4.6¢
 

Sellers (Offers)

Price($) Vol. No.
4.9¢ 15000 1
View Market Depth
Last trade - 16.10pm 26/04/2024 (20 minute delay) ?
Last
4.6¢
  Change
0.001 ( 2.13 %)
Open High Low Volume
4.6¢ 5.0¢ 4.6¢ 240263
Last updated 15.44pm 26/04/2024 ?
RAD (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.